Agostinis P - Search Results

1

Photodynamic therapy of cancer: an update.

Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Agostinis P, et al. CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81. doi: 10.3322/caac.20114. Epub 2011 May 26. CA Cancer J Clin. 2011. PMID: 21617154 Free PMC article. Review.

2

Hypericin in cancer treatment: more light on the way.

Agostinis P, Vantieghem A, Merlevede W, de Witte PA. Agostinis P, et al. Int J Biochem Cell Biol. 2002 Mar;34(3):221-41. doi: 10.1016/s1357-2725(01)00126-1. Int J Biochem Cell Biol. 2002. PMID: 11849990 Review.

3

Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.

Chen B, Roskams T, Xu Y, Agostinis P, de Witte PA. Chen B, et al. Among authors: agostinis p. Int J Cancer. 2002 Mar 10;98(2):284-90. doi: 10.1002/ijc.10175. Int J Cancer. 2002. PMID: 11857421 Free article.

4

Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis.

Vantieghem A, Xu Y, Assefa Z, Piette J, Vandenheede JR, Merlevede W, De Witte PA, Agostinis P. Vantieghem A, et al. Among authors: agostinis p. J Biol Chem. 2002 Oct 4;277(40):37718-31. doi: 10.1074/jbc.M204348200. Epub 2002 Jul 5. J Biol Chem. 2002. PMID: 12101183 Free article.

5

Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers.

Piette J, Volanti C, Vantieghem A, Matroule JY, Habraken Y, Agostinis P. Piette J, et al. Among authors: agostinis p. Biochem Pharmacol. 2003 Oct 15;66(8):1651-9. doi: 10.1016/s0006-2952(03)00539-2. Biochem Pharmacol. 2003. PMID: 14555246 Review.

6

Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells.

Hendrickx N, Volanti C, Moens U, Seternes OM, de Witte P, Vandenheede JR, Piette J, Agostinis P. Hendrickx N, et al. Among authors: agostinis p. J Biol Chem. 2003 Dec 26;278(52):52231-9. doi: 10.1074/jbc.M307591200. Epub 2003 Oct 13. J Biol Chem. 2003. PMID: 14557269 Free article.

7

Regulatory pathways in photodynamic therapy induced apoptosis.

Agostinis P, Buytaert E, Breyssens H, Hendrickx N. Agostinis P, et al. Photochem Photobiol Sci. 2004 Aug;3(8):721-9. doi: 10.1039/b315237e. Epub 2004 Mar 8. Photochem Photobiol Sci. 2004. PMID: 15295626 Review.

8

Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy.

Volanti C, Hendrickx N, Van Lint J, Matroule JY, Agostinis P, Piette J. Volanti C, et al. Among authors: agostinis p. Oncogene. 2005 Apr 21;24(18):2981-91. doi: 10.1038/sj.onc.1208481. Oncogene. 2005. PMID: 15735712

9

Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy.

Hendrickx N, Dewaele M, Buytaert E, Marsboom G, Janssens S, Van Boven M, Vandenheede JR, de Witte P, Agostinis P. Hendrickx N, et al. Among authors: agostinis p. Biochem Biophys Res Commun. 2005 Nov 25;337(3):928-35. doi: 10.1016/j.bbrc.2005.09.135. Epub 2005 Sep 30. Biochem Biophys Res Commun. 2005. PMID: 16214108

10

Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy.

Buytaert E, Callewaert G, Hendrickx N, Scorrano L, Hartmann D, Missiaen L, Vandenheede JR, Heirman I, Grooten J, Agostinis P. Buytaert E, et al. Among authors: agostinis p. FASEB J. 2006 Apr;20(6):756-8. doi: 10.1096/fj.05-4305fje. Epub 2006 Feb 2. FASEB J. 2006. PMID: 16455754

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page